Henshaw Capital’s Idexx Laboratories IDXX Stock Holding History

Henshaw Capital’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-5,169	Closed	-$834K	–	289
2017 Q2	$834K	Sell	5,169 -2,559	-33%	-$416K	0.09%	107
2017 Q1	$1.19M	Sell	7,728 -2,825	-27%	-$389K	0.13%	76
2016 Q4	$1.24M	Hold	10,553	–	–	0.15%	76
2016 Q3	$1.19M	Sell	10,553 -3,242	-24%	-$342K	0.15%	70
2016 Q2	$1.28M	Hold	13,795	–	–	0.17%	63
2016 Q1	$1.08M	Buy	+13,795	New	+$993K	0.14%	71

Other funds holding IDXX

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Henshaw Capital's IDXX Position: Q3 2017 in Review

Henshaw Capital sold out of Idexx Laboratories (IDXX) in Q3 2017, closing a stake of 5,169 shares — an estimated $834K sold.

Henshaw Capital first reported a position in IDXX in Q1 2016 and held it in 6 quarters. The position peaked at $1.28M in Q2 2016. 573 funds tracked by Wall St. Rank hold IDXX as of Q3 2017.

Henshaw Capital reported no remaining Idexx Laboratories position as of Q3 2017 after selling out during the quarter.
Henshaw Capital sold 5,169 Idexx Laboratories shares in Q3 2017, an estimated $834K.
Henshaw Capital first reported a position in Idexx Laboratories in Q1 2016 and held it in 6 quarters.
Henshaw Capital's Idexx Laboratories position peaked at $1.28M in Q2 2016.
573 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2017.

Based on Henshaw Capital's 13F filing for Q3 2017, filed 28 May 2026.